Sort
85,873 grants matching “alzheimers”
Frontotemporal Dementia: Genes, Images, and Emotions
$2,373,110Bruce L Miller · University Of California, San Francisco · P01 · FY2018 · AG
Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study)
$2,372,741Rong Zhang · Ut Southwestern Medical Center · R01 · FY2024 · AG
PREVENTABLE Trial Implementation Phase
$2,372,685Karen P Alexander · Duke University · U19 · FY2022 · AG
The regulation of synaptic transmission and neural circuit function
$2,372,546Wei Lu · National Institute Of Neurological Disorders And Stroke · ZIA · FY2022 · NS
Frontotemporal Dementia: Genes, Images, and Emotions
$2,372,303Bruce L Miller · University Of California, San Francisco · P01 · FY2020 · AG
Anti-Viral therapy in Alzheimer's disease
$2,372,211Davangere P Devanand · Columbia University Health Sciences · R01 · FY2019 · AG
Anti-Viral therapy in Alzheimer's disease
$2,372,211Davangere P Devanand · Columbia University Health Sciences · R01 · FY2020 · AG
MOLECULAR PATHOGENESIS OF AGE-DEPENDENT CNS DEGENERATION
$2,372,020University Of California San Francisco · P01 · FY2002 · AG
Pilot/Exploratory Studies Component
$2,371,937Alexander Keliimoeanu Smith · University Of Colorado Denver · U54 · FY2025 · AG
Predictors of Altered CNS Structure, Function, and Connectomics in the Elderly using a Health Disparities Framework
$2,371,452Ann D. Cohen · University Of Pittsburgh At Pittsburgh · R01 · FY2023 · AG
Validating remote digital assessments for familial frontotemporal dementia
$2,371,437Adam Mark Staffaroni · University Of California, San Francisco · RF1 · FY2022 · AG
Causes and Consequences of Healthcare Efficiency
$2,371,285Amber E Barnato · Dartmouth College · P01 · FY2022 · AG
Pathogenic Roles for Microtubule Stabilization Pathways in Alzheimers disease
$2,370,583Francesca Bartolini · Columbia University Health Sciences · RF1 · FY2022 · AG
Molecular Mechanism and Novel Therapeutic Strategy in Alzheimer's Disease
$2,370,000Liang Feng · Stanford University · DP2 · FY2015 · AG
ALZHEIMERS DISEASE RESEARCH CENTER
$2,369,965University Of Washington · P50 · FY2002 · AG
Computational Biology, Bioinformatics, Imaging & Proteomics Research-RCMI
$2,369,604Robert E Taylor · Howard University · G12 · FY2010 · RR
Impact of Intensive Treatment of Systolic Blood Pressure on Brain Perfusion, Amyloid and Tau in Older Adults (IPAT-study)
$2,369,453Rong Zhang · Ut Southwestern Medical Center · R01 · FY2022 · AG
Frontotemporal Dementia: Genes, Images, and Emotions
$2,368,901Bruce L Miller · University Of California, San Francisco · P01 · FY2019 · AG
Pesticide Use and Markers of ADRD Neurodegeneration among US Farmers
$2,368,557Honglei Chen · Henry Ford Health + Michigan State University Health Sciences · R01 · FY2025 · AG
Blood-brain barrier dysfunction in Alzheimer's disease: from humans to animal models
$2,368,153Hanzhang Lu · Johns Hopkins University · RF1 · FY2021 · AG
The BrainCellQTL consortium: QTL mapping in the human brain at the single cell level
$2,367,336Panagiotis Roussos · Icahn School Of Medicine At Mount Sinai · U24 · FY2025 · AG
Model-based cerebrovascular markers extracted from hemodynamic data for diagnosing MCI or AD and predicting disease progression.
$2,366,514Vasilis Z Marmarelis · University Of Southern California · R01 · FY2020 · AG
Spatial-Temporal Characterization of The Hemodynamic Response to Neural Activity
$2,366,222Afonso Silva · National Institute Of Neurological Disorders And Stroke · ZIA · FY2016 · NS
Impact of change in lifestyle health behaviors on cognition: Harmonizing and leveraging participant-level data from randomized controlled trials
$2,366,213Shannon Halloway · University Of Illinois At Chicago · RF1 · FY2024 · AG
Mechanisms of Circadian and Synaptic Dysfunction After Repetitive Mild TBI
$2,366,184Michael J Whalen · Massachusetts General Hospital · RF1 · FY2022 · NS